Determination of Seroprevalence and Risk Factors of Crimean–Congo Haemorrhagic Fever (CCHF) in the Endemic Region in Turkey: A Population-Based Cross-Sectional Study
Table 5
Logistic regression analysis of some CCHF-related risk factors for anti-CCHFV IgG seropositivity of the participants (n = 2319).
Variables
Anti-CCHFV IgG
value
COR (95% CI)
AOR (95% CI)
Seropozitivity n (%)
Seronegativity n (%)
Location
Urban
70 (5.2)
1284 (94.8)
0.28
Ref.
Rural
60 (6.2)
905 (93.8)
1.22 (0.85–1.74)
Farming
No
93 (4.7)
1875 (95.3)
<0.001
Ref.
Ref.
Yes
37 (10.5)
314 (89.5)
2.38 (1.59–3.54)
1.84 (1.18–2.86)
Animal husbandry
No
66 (4.3)
1485 (95.7)
<0.001
Ref.
Ref.
Yes
64 (8.3)
704 (91.7)
2.05 (1.43–2.92)
1.64 (1.04–2.27)
Having a pet at home
No
104 (5.4)
1806 (94.6)
0.467
Ref.
Yes
26 (6.4)
383 (93.6)
1.18 (0.76–1.84)
Tick contact history
No
93 (4.8)
1856 (95.2)
<0.001
Ref.
Ref.
Yes
37 (10)
333 (90)
2.22 (1.49–3.30)
1.02 (1.03–2.29)
Duration of with tick contact
≤1 year
15 (12.2)
108 (87.8)
0.293
Ref.
2–4 years
13 (11.4)
101 (88.6)
0.93 (0.42–2.04)
≥5 years
9 (6.8)
124 (93.2)
0.52 (0.22–1.24)
Hospitalization with suspected CCHF
No
121 (5.3)
2174 (94.7)
<0.001
Ref.
Ref.
Yes
9 (37.5)
15 (62.5)
10.78 (4.62–5.13)
6.65 (2.70–16.43)
Is there anyone in your family who was treated for CCHF?
No
117 (5.4)
2040 (94.6)
0.165
Ref.
Yes
13 (8)
149 (92)
1.52 (0.84–2.77)
If there is anyone in your family who was treated for CCHF, what is the health status? (n = 162)
Is alive
11 (7.4)
138 (92.6)
0.308
Ref.
Is dead
2 (15.4)
11 (84.6)
2.28 (0.45–11.61)
Is there anyone diagnosed with CCHF where you live?
No
95 (4.8)
1864 (95.2)
<0.001
Ref.
Ref.
Yes
35 (9.7)
325 (90.3)
2.11 (1.41–3.17)
1.66 (1.08–2.56)
If there is anyone diagnosed with CCHF where you live, what is the health status? (n = 360)
Is alive
22 (9.1)
220 (90.9)
0.563
Ref.
Is dead
13 (11)
105 (89)
1.24 (0.60–2.55)
Anti-CCHFV IgG, anti-Crimean–Congo haemorrhagic fever virus immunoglobulin G; COR, crude odds ratio; AOR, adjusted odds ratio; CI, confidence interval; value of Yates’ corrected X2 test for anti-CCHFV IgG serology subgroup comparison.